(3) Rescission of provisional approval If the Secretary determines that the side effect profile of any drug included in such observational registries does not support the benefit provided by such drug, or that the data shows that the benefit is less than the benefits offered through other, drugs approved under section 505 of this Act or section 351 of the Public Health Service Act, the Secretary shall rescind such provisional approval. (i) Duration of provisional approval